featured
Two Doses of the COVID-19 Vaccine BNT162b2 Are Required for Patients With Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Immunogenicity of One Versus Two Doses of the COVID-19 Vaccine BNT162b2 for Patients With Cancer: Interim Analysis of a Prospective Observational Study
Lancet Oncol 2021 Apr 27;[EPub Ahead of Print], L Monin, AG Laing, M Muñoz-Ruiz, DR McKenzie, I Del Molino Del Barrio, T Alaguthurai, C Domingo-Vila, TS Hayday, C Graham, J Seow, S Abdul-Jawad, S Kamdar, E Harvey-Jones, R Graham, J Cooper, M Khan, J Vidler, H Kakkassery, S Sinha, R Davis, L Dupont, I Francos Quijorna, C O'Brien-Gore, PL Lee, J Eum, M Conde Poole, M Joseph, D Davies, Y Wu, A Swampillai, BV North, A Montes, M Harries, A Rigg, J Spicer, MH Malim, P Fields, P Patten, F Di Rosa, S Papa, T Tree, KJ Doores, AC Hayday, S IrshadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.